Objective: Epicardial fat is an indirect contact with coronary arteries. There are some studies about the relationship between this fat and metabolic syndrome and it has considered as an indicator of cardiovascular risk. Several studies have addressed the association between epicardial fat thickness (EFT) and coronary artery disease (CAD) with conflicting results. The aim of our study was to evaluate the hypothesis that echocardiographic EFT thickness could be a marker severe CAD. Methods: Overall, 315 cases who underwent coronary angiography were classified in two groups: Normal and CAD. Measurement of EFT was done with echocardiography. The difference between mean EFT in two groups was analyzed. Califf scoring considered for severity of CAD. Then the relationship between EFT and age, sex, body mass index (BMI), serum lipids and severity of CAD was evaluated. The obtained data were compared by using ANCOVA test, Pearson and Spearman's partial correlation analyses. Results: The EFT in CAD group was significantly higher than in normal group (5.4±1.9 mm vs 4.4±1.8mm, p=0.0001). EFT had a positive relationship with Califf scoring of diseased coronary arteries (r=0.158 p=0.04), low-density lipoprotein cholesterol (p=0.04), female gender (p=0.02), BMI (p=0.001) and serum triglyceride levels (p=0.04). 
Introduction
Visceral adiposity is a fat deposition around internal organs. It is metabolically active and is an important risk factor for developing the metabolic syndrome (MS) (1) (2) (3) (4) . It is widely recognized that accumulation of abdominal visceral fat is strongly related to the development of coronary artery disease (CAD) (4) (5) (6) (7) (8) (9) . It suggested that epicardial fat thickness (EFT) may reflect the amount of visceral fat, which is associated with insulin resistance and inflammation (10) . EFT is also known to be a rich source of free fatty acids and a number of bioactive molecules and inflammatory cytokines (11) (12) (13) (14) . Visceral adipose tissue thickness is associated with hip and thigh circumference or subcutaneous fat thickness (15) . EFT was significantly higher in patients with nonalcoholic fatty liver disease (16) . Pathological investigations revealed EFT and the adventitia of coronary arteries or myocardium to be contiguous, with no intervening structures (10) .
Some reports have suggested a crucial role of EFT in the development of CAD through changes in adipokine expressions in EFT, which promote pro-inflammatory characteristics, thereby possibly facilitating the progression of coronary atherosclerosis (12) (13) (14) (15) .
Transthoracic echocardiography enables non-invasive assessment of EFT (3, 14) . Conceptually, this peri-coronary fat might be most interesting because of its close anatomic relation with the coronary arteries. EFT was significantly increased in women with microvascular dysfunction (17) and individual with a higher detectable carotid atherosclerosis (18) . But some studies suggested correlation between severity of obstructive coronary artery stenosis and EFT (19, 20) . Several investigations of the relation between EFT and the severity of coronary stenosis in patients have produced conflicting results (20) (21) (22) . Califf scoring is a reliable system for the quantification of jeopardized myocardium and severity of coronary stenosis (23, 24) . Yet correlation between severity of coronary artery stenosis and EFT with this scoring system was not done.
Therefore, the aim of our study was to evaluate the hypothesis that echocardiographic EFT thickness could be a marker for severity of CAD.
Methods

Study design
The study was designed as an observational cross-sectional study.
This study has been confirmed by the Ethic Committee of Esfahan Medical Sciences University and all the participants were informed of its objectives before the study and signal a letter of consent in accordance with the Helsinki Declaration Standards.
Patients
In a cross-sectional study, 315 patients who were candidate for coronary angiography due to chest pain (e.g. acute coronary syndrome and/ or chronic stable angina) and/or an abnormal stress test were selected.
The inclusion criteria were: normal respiration, normal anatomical chest, and stable sinus rhythm.
Patients were excluded if they had abnormal images on transthoracic echocardiography or poor echo window, a history of coronary artery bypass graft surgery (CABG), percutaneous coronary intervention (PTCA), chronic kidney disease, pericardial and/or pleural effusion.
Variables
Body mass index (BMI) was calculated as body weight divided by height squared. Hypertension was defined as systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, or requirement for antihypertensive medication (25) . Diabetes mellitus was defined according to the criteria of the American Diabetes Association (26) , or requirement for insulin or oral hypoglycemic drugs. Hyperlipidemia was defined as use of a lipid-lowering agent, low-density lipoprotein cholesterol (LDL) cholesterol equal or greater than 160 mg/dl, or total cholesterol higher than 220 mg/d or triglycerides ≥150 mg/dl (27) . CAD was defined with presence of 75 percent cross-sectional stenosis or more of at least one major coronary artery. Height (m) and weight (kg) were used to calculated body mass index. Obesity was defined as having a BMI ≥30 kg/m 2 (27) .
Protocol of the study After coronary angiography, all patients underwent transthoracic echocardiography. Systolic and diastolic blood pressures were measured after 5 min of rest. Height, waist circumference (WC), weight and body fat ratio (Tanita TBF 534, Japan) were measured during a fasting period.
Echocardiographic measurement
Transthoracic echocardiography provides a reliable measurement of EFT (14) . Epicardial fat appears as an echo free space on left and right ventricles and if it is massive, is a hyperechoic space. In this apace there is a scattered reflection that is adjacent to ventricles and move with them. This is characteristic of epicardial fat. The highest diameter of this fat is on right ventricular free wall. The subcostal four chamber and parasternal long and short axis echocardiogram views show this finding in best way (28, 29) . A normal upper-limit value for EFT has not been established yet (30) .
Differentiation from pericardial effusion is done with location and density of echo.
Echocardiography was performed by only one operator using Vivid-3, GE (United States, probe number 2.5) instrument, which has a 3.5 MHZ transducer and is capable of M-mode, 2D and Doppler study. The operator and the subjects did not know the results of coronary angiography (normal or diseased coronary arteries) at the time of echocardiography.
The subjects lied on left lateral decubitus position and the fat thickness was measured on free wall of right ventricle at end systole because of: 1. this point has highest absolute epicardial fat layer thickness and 2. parasternal long-and short -axis views allow the most accurate measurement of epicardial fat on right ventricle with optimal cursor beam orientation. The average value from 3 cardiac cycles for each echocardiographic view was used for the statistical analysis (30) (Fig. 1) . To assess the reproducibility of the echocardiographic measurements, EFT thickness was measured by two independent echocardiographers in 22 randomly selected patients and inter-observer correlation coefficients were calculated. In the same group of patients, echocardiographic measurements were repeated 1 day later to calculate intra-observer correlation coefficients. Variability of measurements were also calculated as the mean of differences in measurements.
Coronary angiography data All cases undergo diagnostic coronary angiography. Major coronary vessels were defined as the left main, left anterior descending, circumflex, and right coronary artery. Patients with slow flow in the absence of any discernible lesions were also excluded. By considering cut-off point 75% for the definition of significant stenosis, Califf scoring was appropriate for defining severity of CAD (31). Califf scoring system for purposes of determining the severity of Coronary stenosis is considered as six arterial segments the left anterior descending artery, major diagonal, the first major septal branch, the left circumflex artery, the major obtuse marginal and the right coronary artery. In patients with a left dominant system, RCA is assigned no points. Each segment with a 75% or greater stenosis is given a score of 2 points. Each vessel distal to a 75% or greater stenosis is also given a score of 2 points (31). Coronary angiograms were interpreted by two independent invasive cardiologists. Interobserver agreement of the angiographic interpretation was assessed with a between-observer coefficient of variation. However, there is significant intra-and interobserver agreement with regard to angiographic evaluation of the extent of coronary stenosis.
Statistical analysis
Statistical analysis was done using SPSS 16.0 for Windows software (SPSS Inc., Chicago, IL, US). All data were expressed as mean±standard deviation. The difference of mean EFT in normal and CAD groups were compared with unpaired Student's t test and with 95 percent confidence interval. Pearson correlation analysis was used for analysis of correlation between EFT and age, BMI, serum lipids and WC. The effect of EFT on the presence and severity (Califf scoring) of CAD was assessed using analysis of covariance (ANCOVA) and Spearman's partial correlation analysis, controlling for the intervening factors including: diabetes, sex, age, smoking, LDL, BMI. Distribution of diabetes, hypertension and smoking in normal and CAD group was analyzed with Chi-square test. Statistical significance was set at <0.05.
Results
Demographic features
Of the 315 patients 23 cases were excluded, 15 cases because of poor echocardiographic window and 8 cases because of pericardial effusion.
Finally, 292 subjects in the range of 32-85 years were included. Mean ages of Normal and CAD groups were 54±8.6 and 59±10 years, respectively with statistical significant difference (p=0.001). Overall, 64 (51.2%) and 111 (64.9%) males were in normal and CAD groups respectively so there was a gender difference (p=0.02) in two groups (Table 1) .
Cardiovascular risk factors distribution in groups
Distribution of diabetes (p=0.03), and smoking (p=0.001) in two groups was significantly different (Table 1) , but hypertension did not differ (p=0.3).
Mean of serum LDL level was significantly higher in CAD group (p=0.04) as compared to Normal group.
EFT and clinical variables
Epicardial fat thickness varied between1-13.5 mm. Mean of thickness in normal group was 4.4±1.8 mm and in CAD group 5.4±1.9 mm (Fig. 2) that was statistically significant (p=0.0001). Additional ANCOVAs in both groups (normal and CAD), with discussion of diabetes, sex, age, smoking, LDL, BMI, as dependent variables, showed that the differences in EFT between both groups had significantly influenced the CAD presence (p=0.0001) ( Table 2 ). EFT had a positive correlation with LDL, BMI (p=0.001), serum triglyceride (p=0.04) and WC (p=0.04) ( Table 3 ). Epicardial fat thickness was higher in females (Table 4) .
Correlation EFT and severity of coronary diseases
Correlation EFT with severity of CAD with Spearman's analysis (Spearman r=0.3, p=0.0001) is defined but despite confounding variables again EFT had positive correlation with the severity of coronary diseases (Califf scoring) by controlling (partial correlation) confounding variables (Spearman r=0.213 p=0.002). Mean of Califf scoring in CAD group was 6.2. Figure 1 . Echocardiographic epicardial fat thickness (EFT). EFT (thick arrow) can be identified as the echo free space between outer wall of the myocardium and visceral layer of pericardium (thin arrow) in the parasternal long-axis view. EFT is measured during end-systole at the point on the free wall the right ventricle along the midline of the ultrasound beam, with the best effort to be perpendicular to the aortic annulus, used as an anatomic landmark
Discussion
This study shows the association of EFT with severity of CAD. EFT may thus be increased in the presence of atherosclerotic plaque. In addition, it may be related to cardiovascular risk factors and metabolic syndrome (MS) (4). Our study showed correlation between cardiovascular risk factors (smoking, diabetes, obesity, hyperlipidemia, age) and EFT. Distribution of traditional risk factors such as age, male sex, diabetes, smoking and serum LDL had significant difference in normal and CAD groups. This subject may have confounding effect on our results, but by controlling (ANCOVA test) these factors, the correlation between EFT and presence of CAD was defined (p=0.0001) independently.
EFT thickness emerged as an independent predictor of CAD among other well-known risk factors (32) .
Two potential mechanisms for this association have been proposed: first, EFT is a component of visceral adiposity and is related to metabolic syndrome and cardiovascular risk factors (1-4) , secondly, EFT has paracrine and endocrine functions. It can secrete numerous bioactive molecules (adipokines) such as adiponectin, resistin and inflammatory cytokines (interleukin -1b, interleukin -6, tumor necrosis factor-α) (13, 33) . Interestingly, inflammatory mediators originating outside the coronary artery are also capable of including compositional changes in the inner layer of intima (34, 35) .
There is a growing evidence that the changes in or perivascular tissue surrounding epicardial coronary arteries could alter vascular homeostasis and contribute to endothelial dysfunction, amplification of vascular inflammation, intimal lesions, plaque progression by an "outside-to-inside"x signaling mechanism (34-37). Atherosclerosis and atherothrombosis have been identified as an inflammatory disease (38) Sacks et al. (10) pointed out the paracrine and vasocrine signaling effects of epicardial adipokines for the development of atherogenesis. Data are presented as mean±SD and number/percentage *Chi-square and unpaired Student's t-tests CAD -coronary artery diseases, DM -diabetes mellitus, EFT -epicardial fat thickness, HT-hypertension, LDL -low -density lipoprotein, Tg -triglyceride It seems that EFT is a part of active adipose tissue that can affects the coronary circulation via secretion of inflammatory mediators and adipokines (12) .
However, there is a substantial amount of data demonstrating associations between increased EFT thickness and volume as assessed by echocardiography and coronary atherosclerosis. It is of note that some of the studies indicate that an increased amount of EFT is either not related to CAD or is merely a marker of visceral and overall adiposity and that adding it to the already existing cardiovascular risk assessment models does not enhance their predictive capabilities (39, 40) .
These discrepancies may be to some extent the result of varying methodologies and study populations. We also showed that EFT independently was related to severity (p=0.042) of CAD.
The correlation between EFT thickness and the severity of CAD has been addressed previously (19, 20) . However, the results of these studies are conflicting, as they did not assess patients with normal coronary arteries.
Ahn et al. (10) showed that EFT was thicker in subjects with CAD than in those without CAD, and that it might provide additional information for assessing CAD risk and predicting the extent and activity of CAD.
In this study, we defined that increased EFT correlated with multiple and severe coronary artery stenosis without confounding effect of dependent variables.
In our study, EFT on the right ventricle varied between 1 and 13.5 mm, which was similar to those reported in a recent study (1.8-16 .5mm) (14) . Epicardial fat thickness was higher in females ( Table 4) that may be because of higher BMI in females than in men.
Inflammation has been identified as a potential target for therapeutic intervention in patients with CAD (39) . Inflammatory mediators derived EFT was favorable target for preventive intervention and novel therapeutic strategies, that these interventions (such as aspirin, angiotensin-converting enzyme inhibitor, statin, and specially exercise and weight loss) may also have anti-inflammatory effect and decreasing epicardial fat volume, but more studies are required for approving this hypothesis.
Study limitations
To further clarify the possible relation between fat surrounding, coronary arteries and the development of CAD, it is important to reliably quantify this adipose tissue. In a few studies, adipose tissue around the heart has been measured by magnetic resonance imaging (MRI), computed tomography (CT) or echocardiography (41) (42) (43) (44) . Furthermore, there are differences in anatomic description (pericardial versus epicardial fat) and measurement techniques (volume or thickness) (41, 42, 44) .
A measurement of adipose tissue directly surrounding the coronary arteries has not been published.
We could not confirm epicardial fat using the standard MRI and CT methods. Echocardiography was a relatively simple and inexpensive method, but the accuracy and reproducibility should be further tested. In addition, as epicardial adipose tissue has a 3-dimensional distribution, 2-dimensional echocardiography may not completely assess the total amount of epicardial adiposity. Further study will be necessary.
Conclusion
In our study, thickness of epicardial fat layer was higher in CAD group than in normal group. EFT measured using transthoracic echocardiography significantly correlated with the severe multiple of coronary artery stenosis in patients with known coronary artery disease. Also, epicardial fat thickness as a marker of severity of coronary lesions. These findings may enhance the utility of echocardiography as an assessment tool for patients' adiposity and, if confirmed, can assist in the risk stratification of patients with coronary artery disease. Complementary studies in this field are recommended.
